Free Trial

Outset Medical Q3 2023 Earnings Report

Outset Medical logo
$10.91 -0.15 (-1.36%)
As of 04:00 PM Eastern

Outset Medical EPS Results

Actual EPS
-$13.95
Consensus EPS
-$11.85
Beat/Miss
Missed by -$2.10
One Year Ago EPS
N/A

Outset Medical Revenue Results

Actual Revenue
$30.36 million
Expected Revenue
$30.38 million
Beat/Miss
Missed by -$20.00 thousand
YoY Revenue Growth
N/A

Outset Medical Announcement Details

Quarter
Q3 2023
Time
N/A

Conference Call Resources

Conference Call Audio

Remove Ads

Outset Medical Earnings Headlines

Trump’s Secret Weapon
Have you looked at the stock market recently? Millions of investors are scrambling trying to figure out what's coming next. But here's the truth… This is just the beginning. Trump has made it clear his tariffs are coming, and that the market will get worse before it gets better. Luckily, our FREE Presidential Transition Guide details exactly what will happen in the next 100 days, and how to protect your hard-earned savings during these times. Don't wait for the next crash to wipe you out. Act now.
Outset Medical trading halted, volatility trading pause
See More Outset Medical Headlines
Get Earnings Announcements in your inbox

Want to stay updated on the latest earnings announcements and upcoming reports for companies like Outset Medical? Sign up for Earnings360's daily newsletter to receive timely earnings updates on Outset Medical and other key companies, straight to your email.

About Outset Medical

Outset Medical (NASDAQ:OM), a medical technology company, engages in the development of a hemodialysis system for hemodialysis in the United States. The company offers Tablo Hemodialysis System, a compact console with integrated water purification, on-demand dialysate production, and software and connectivity capabilities for dialysis care in acute and home settings; and manufactures, supports, and distributes for Tablo console, Tablo cartridge, and other consumables. It also provides Tablo Data Ecosystem, including TabloHub, a customer-facing portal; MyTablo, a patient-facing portal; and TabloDash, an internal data analytics platform. The company was formerly known as Home Dialysis Plus, Ltd. and changed its name to Outset Medical, Inc. in January 2015. Outset Medical, Inc. was incorporated in 2003 and is headquartered in San Jose, California.

View Outset Medical Profile

More Earnings Resources from MarketBeat